Celgene (CELG) Reports EMA CHMP Adopts Positive Opinion for Pomalidomide

May 31, 2013 6:26 AM EDT Send to a Friend
Celgene Corp (Nasdaq: CELG) unit, Celgene International Sàrl, announced that the European Medicines Agency’s (EMA): Committee for Medicinal Products for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login